Daniel Wendisch
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- Inflammasome and immune disorders 1
-
- Immune cells in cancer 3
- Inflammation biomarkers and pathways 1
- Co-authors
- Florian Kurth (3 shared papers)Victor M. Corman (2 shared papers)Linda Jürgens (3 shared papers)Miriam Stegemann (3 shared papers)Leif Erik Sander (4 shared papers)Kathrin Heim (2 shared papers)Max von Kleist (1 shared paper)Ehsan Vafadarnejad (2 shared papers)
- Journals
- Infection (1 paper)Nature (1 paper)Cell (1 paper)medRxiv (1 paper)
- Partner nations
- GermanyNetherlandsItaly
In The Last Decade
Daniel Wendisch
5 papers receiving 875 citations
Daniel Wendisch's Hit Papers
Peers
Comparison fields: 5 of 76
- Infectious Diseases 445
- Neurology 225
- Immunology 318
- Virology 46
- Critical Care and Intensive Care Medicine 18
Countries citing papers authored by Daniel Wendisch
This map shows the geographic impact of Daniel Wendisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wendisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wendisch more than expected).
Fields of papers citing papers by Daniel Wendisch
This network shows the impact of papers produced by Daniel Wendisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wendisch. The network helps show where Daniel Wendisch may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Wendisch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment Hit paper breakdown → | 2020 | 802 |
| 2 | 2022 | 43 | |
| 3 | Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses Hit paper breakdown → | 2025 | 27 |
| 4 | 2020 | 12 | |
| 5 | 2023 | 1 |
About Daniel Wendisch
Daniel Wendisch is a scholar working on Molecular Biology, Immunology, Infectious Diseases, Epidemiology and Neurology, having authored 5 papers that have together received 885 indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), COVID-19 Clinical Research Studies (2 papers), Long-Term Effects of COVID-19 (1 paper), Poxvirus research and outbreaks (1 paper), Inflammation biomarkers and pathways (1 paper), Herpesvirus Infections and Treatments (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Inflammasome and immune disorders (1 paper). The work is most often cited by research in Infectious Diseases (445 citations), Neurology (225 citations), Immunology (318 citations), Virology (46 citations) and Critical Care and Intensive Care Medicine (18 citations). Daniel Wendisch has collaborated with scholars based in Germany, Netherlands and Italy. Frequent co-authors include Florian Kurth, Victor M. Corman, Linda Jürgens, Miriam Stegemann, Leif Erik Sander, Kathrin Heim, Max von Kleist, Ehsan Vafadarnejad, Thomas Ulas and Antoine‐Emmanuel Saliba. Their work appears in journals such as Infection, Nature, Cell and medRxiv.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.